Yahoo Finance

Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Program

MURI BEI BERN, Switzerland, January 20, 2026--(BUSINESS WIRE)--Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its novel ...
Nature

Assessment of Inferior Vena Cava and Central Venous Pressure in Clinical Practice

The assessment of the inferior vena cava (IVC) and central venous pressure (CVP) has emerged as a pivotal aspect in the optimisation of haemodynamic management across a range of clinical settings.
Morningstar

Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Program

Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its novel solution designed to directly measure central venous pressure ...
Finanznachrichten

Compremium AG: Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA's TAP Program

Novel solution aims to transform clinical pathways for critical hemodynamic monitoring Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...